Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 20, 18 Issues, 2020
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Ranking and Category
-
39th of 61 in
Chemistry, Medicinal
-
172nd of 229 in
Oncology
Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 14 - Number 6
Editorial
Novel Mechanisms of Anticancer Activities of Green Tea Component Epigallocatechin- 3-Gallate
, 14(6): 779 - 786Le Zhang, Yaqing Wei and Jinsong Zhang
DOI: 10.2174/1871520614666140521114327
Curcumin: A Promising Agent Targeting Cancer Stem Cells
, 14(6): 787 - 792Shufei Zang, Tao Liu, Junping Shi and Liang Qiao
DOI: 10.2174/1871520614666140521114735
Garlic-Derived Allyl Sulfides in Cancer Therapy
, 14(6): 793 - 799Hai-Xia Cao, Ke-Xiang Zhu, Jian-Gao Fan and Liang Qiao
DOI: 10.2174/1871520614666140521120811
The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer
, 14(6): 800 - 805Jiezhong Chen, Adam O’Donoghue, Yi-Fu Deng, Bing Zhang, Fanning Kent and Tim O’Hare
DOI: 10.2174/1871520614666140521121317
From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
, 14(6): 806 - 825Xuan Yang, Xun Li and Jinyu Ren
DOI: 10.2174/1871520614666140521121722
Nanoparticle-Delivered Quercetin for Cancer Therapy
, 14(6): 826 - 832Ke Men, Xingmei Duan, Xia Wei Wei, Ma Ling Gou, Mei Juan Huang, Li Juan Chen, Zhi Yong Qian and Yu Quan Wei
DOI: 10.2174/1871520614666140521122932
Paris polyphylla: Chemical and Biological Prospectives
, 14(6): 833 - 839Jagmohan S. Negi, Vinod K. Bisht, Arvind K. Bhandari, Vijay P. Bhatt, Pramod Singh and Narayan Singh
DOI: 10.2174/1871520614666140611101040
Research Article
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
, 14(6): 840 - 851Georgina A. Cardama, Maria J. Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G. Turjanski, Daniel F. Alonso, Daniel E. Gomez and Pablo Lorenzano Menna
DOI: 10.2174/18715206113136660334
Research Article
Targetability and Biodistribution of Radioiodinated Hypericin: Comparison between Microdosing and Carrier-Added Preparations
, 14(6): 852 - 861Marlein Miranda Cona, Junjie Li, Yuanbo Feng, Feng Chen, Alfons Verbruggen, Peter de Witte, Raymond Oyen and Yicheng Ni
DOI: 10.2174/18715206113136660360
The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System
, 14(6): 862 - 871Pierre Champelovier, Pascale Barbier, Etienne Daras, Soazig Douillard, Bertrand Toussaint, Virginie Persoon, Veronique Curri, Vincent Peyrot and Sebastien Combes
DOI: 10.2174/1871520614666140223190829
Research Article
Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines
, 14(6): 872 - 883Tanushree Pal, Hardik Joshi and C.S. Ramaa
DOI: 10.2174/1871520614666140528155118
Research Article
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
, 14(6): 884 - 891Mifang Yang, Xia Shan, Xin Zhou, Tianzhu Qiu, Wei Zhu, Yin Ding, Yongqian Shu and Ping Liu
DOI: 10.2174/1871520614666140528161318
Research Article
The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery
, 14(6): 892 - 900Adeleh Divsalar, Mahdieh Razmi, Ali Akbar Saboury and Arefeh Seyedarabi
DOI: 10.2174/1871520614666140207123147
Research Article
Role of Caspases, Bax and Bcl-2 in Chrysin-Induced Apoptosis in the A549 Human Lung Adenocarcinoma Epithelial Cells
, 14(6): 901 - 909Saeed Samarghandian, Mohsen Azimi Nezhad and Gholamreza Mohammadi
DOI: 10.2174/1871520614666140209144042
Research Article
Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents
, 14(6): 910 - 920Vikas Kumar, Akshay Kumar, Vommina V. Sureshbabu and Swapandeep S. Chimni
DOI: 10.2174/18715206113136660368
  |
Editor-in-Chief
Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
View Full Editorial Board
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
Biography of Michelle Prudhomme
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Webmaster Contact: info@benthamscience.net